Full history for every metric is available with a Kvantra account
Zymergen Inc. (ZY)
Key financial summary
Financials in USD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | - | 15 | 13 | 17 | 14 |
| Operating profit | $m | -347 | -338 | |||||
| Net profit | $m | - | - | - | -237 | -262 | -362 | -365 |
| EPS reported | $ | -4.87 | -3.55 | |||||
| Operating cashflow per share | $ | -4.07 | -4.07 | |||||
| Capex per share | $ | 0.45 | 0.45 | |||||
| FCF per share | $ | -4.52 | -4.52 | |||||
| Free cash flow | $m | -336 | -262 | |||||
| Net debt | $m | -342 | -214 | |||||
| Book value equity | $m | 408 | 237 | |||||
| Book value per share | $ | 5.50 | 2.29 | |||||
| Number of shares | m | 74.31 | 103.48 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.22 | 1.06 | |||||
| P/S LTM | x | 29.69 | 17.84 | |||||
| P/FCF LTM | x | -1.48 | -0.96 | |||||
| EV/EBITDA LTM | x | -0.47 | -0.12 | |||||
| EV/Sales LTM | x | 9.25 | 2.69 | |||||
| Earnings Yield LTM | % | -72.78% | -200.36% | |||||
| FCF Yield | % | -67.57% | -104.14% | |||||
| Quality | ||||||||
| ROE | % | -88.57% | 215.83% | |||||
| ROIC | % | -70.42% | -70.42% | |||||
| Operating margin | % | -2072.7% | -2072.7% | |||||
| Gross margin | % | -316.42% | -316.42% | |||||
| FCF/Sales | % | -2006.2% | -2006.2% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +26.04% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -7.64 | -1.41 | |||||
| Net Debt/EBITDA | x | 1.05 | 1.05 | |||||
| EBIT/Net interest | x | -23.60 | -23.60 | |||||
| Net debt/market cap | % | -68.83% | -84.93% | |||||
| Net debt/Equity | x | -0.84 | -0.90 | |||||
| Gross debt/equity | x | 0.11 | 0.79 | |||||
Company overview
Zymergen Inc. specializes in the creation, advancement, and market introduction of various biological entities and substances, including microorganisms, specialized molecules, and novel materials. The company provides an advanced automation platform, which incorporates adaptable automation carts—modular hardware components enabling the construction of laboratory work cells tailored to specific research requirements. Additionally, it features cloud-based automation control software designed to manage integrated automated systems efficiently. Zymergen's diverse clientele spans sectors such as electronics, packaging, healthcare, agriculture, and others. Established in 2013, Zymergen Inc. is headquartered in Emeryville, California. Since October 19, 2022, the company has operated as a subsidiary under Ginkgo Bioworks Holdings, Inc.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Zymergen Inc. (ZY)
Zymergen Inc. specializes in the creation, advancement, and market introduction of various biological entities and substances, including microorganisms, specialized molecules, and novel materials. The company provides an advanced automation platform, which incorporates adaptable automation carts—modular hardware components enabling the construction of laboratory work cells tailored to specific research requirements. Additionally, it features cloud-based automation control software designed to manage integrated automated systems efficiently. Zymergen's diverse clientele spans sectors such as electronics, packaging, healthcare, agriculture, and others. Established in 2013, Zymergen Inc. is headquartered in Emeryville, California. Since October 19, 2022, the company has operated as a subsidiary under Ginkgo Bioworks Holdings, Inc.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free